Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study
<strong>Background</strong> In 2017, an estimated 14 million cases of Plasmodium vivax malaria were reported from Asia, Central and South America, and the Horn of Africa. The clinical burden of vivax malaria is largely driven by its ability to form dormant liver stages (hypnozoites) that...
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Journal article |
| Taal: | English |
| Gepubliceerd in: |
Public Library of Science
2021
|